Vivienne Parry talks to Doug Doerfler, President & CEO MaxCyte is a clinical-stage global cell-based therapies and life sciences company that believes in the power of next-generation cell and gene therapies to revolutionize medical treatment and ultimately save lives. For more healthcare content, visit: https://www.edisongroup.com/our-content/?sector=healthcare
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.